SV Health Investors is a venture capital firm in Massachusetts that focuses on biotechnology and healthcare industry. Founded 1993 in Boston, Massachusetts, United States, it invests in debt, early stage ventures, late stage ventures, series B, series A, and series D rounds. Its portfolio companies include Xilio Therapeutics, EBT Medical, Ervaxx, Healthify, Clarify Medical, Bardy Diagnostics, CSA Medical, Rheostat Therapeutics, Ribometrix, and Urgent Team Holdings, Inc. As of April 2020, SV Health Investors has made 216 investments. Their most recent investment was on March 2, 2020, when Xilio Therapeutics raised $100.5M. V Health Investors has had 38 exits, the most notable of which include Bicycle Therapeutics, Avrobio, and Sutro Biopharma. The company has raised seven funds, their latest being SV7 Growth Fund.
Timeline
Associated investment funds
People
David Milne
Managing Partner
Jacqueline Grant
Senior Associate
Michael Balmuth
Managing Partner
Further reading
Documentaries, videos and podcasts
Companies
EBT Medical
Ervaxx
Healthify
Xilio Therapeutics
News
References
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Lax Mariappan
Technopreneur, Open source enthusiast, author, speaker. Co-founder of Eternus Global. Crafting applications for the medical industry. - 2
Reys Phillips
A graduate of Cleveland State University with a Bachelor of Science in Education. My main hobbies include story writing and reading. - 3
Jed Christiansen
Special Projects & Business Development at Golden, Founder - Seed-DB. - 4
Aime Anne Nisay
QA Engineer of web and mobile applications - 5
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 6
Edita Rexha
Economist